GOLDMAN SACHS GROUP INC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 59 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274,356
+165.3%
46,344
+232.5%
0.00%
Q2 2023$103,427
-88.2%
13,939
-85.0%
0.00%
Q1 2023$879,937
+718.9%
93,115
+822.8%
0.00%
Q4 2022$107,459
+45.2%
10,090
+0.3%
0.00%
Q3 2022$74,00010,0550.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Corton Capital Inc. 13,966$103,0000.13%
Delphia (USA) Inc. 14,226$105,0000.12%
Sentinus, LLC 22,500$166,0000.10%
Intrepid Financial Planning Group LLC 20,000$148,0000.08%
PERRITT CAPITAL MANAGEMENT INC 12,000$89,0000.06%
J. Goldman & Co LP 148,738$1,098,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$657,0000.02%
EMFO, LLC 1,666$12,0000.01%
Virtu Financial LLC 12,590$93,0000.01%
Jump Financial, LLC 23,400$173,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders